Key facts
- It has raised $4.8M across 1 recorded rounds; the latest was Seed Round ($4.8M) in Mar 2024.
- Notable investors include Elevate Capital, Oregon Nanoscience and Microtechnologies Institute, Laboratorios Sophia, Philip Knight, VertueLab.
- Osheru has filed 2 Form Ds with the SEC since 2024, most recently Sep 2025 ($4.8M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Osheru
Funding rounds
1 roundsAbout Osheru
Operator of a medical device company intended to revolutionize eyelid surgery. The company allows surgeons to remove excessive eyelid skin safely and effectively while reducing bleeding, bruising, and swelling and eliminating cautery and suturing creates a youthful, alert and revitalized appearance and improves peripheral vision, enabling patients to become event-ready to return to work and activities.
- Sector
- Healthcare
- HQ
- Bend, OR, United States
- Founded
- 1987
- Employees
- 8
- Website
- ziplyft.com/
- Ownership
- Privately Held (backing)
Osheru doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Osheru shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Osheru in its N-PORT filings yet. We sweep new filings monthly.